"CISA Warns of Critical Vulnerabilities in Illumina Genetic Analysis Devices"
The US Cybersecurity and Infrastructure Security Agency (CISA) has issued an advisory to warn of critical vulnerabilities in Illumina genetic analysis devices that could allow a remote, unauthenticated attacker to take over an impacted product. The flaws affect Illumina Local Run Manager (LRM), which is used by sequencing instruments designed for clinical diagnostic use in the sequencing of a person's DNA, testing for various genetic conditions, as well as research. CISA is warning about four "critical severity" vulnerabilities and one " high severity" vulnerability that can be exploited to execute arbitrary code, to achieve directory traversal, upload arbitrary files, connect without authentication, and perform man-in-the-middle attacks. Tracked as CVE-2022-1517, CVE-2022-1518, and CVE-2022-1519, the most severe of these vulnerabilities feature a CVSS score of 10. These three vulnerabilities allow for remote code execution at operating system level (LRM runs with elevated privileges), the upload of data outside the intended directory structure, and the upload of arbitrary files. The fourth critical issue, CVE-2022-1521 (CVSS score of 9.1), exists because, by default, LRM does not feature authentication or authorization, which may allow an attacker to inject, intercept, or tamper with sensitive data. The fifth vulnerability is tracked as CVE-2022-1524 (CVSS score of 7.4), and it exists because TLS encryption is missing in LRM version 2.4 and lower, thus allowing a malicious actor to perform a man-in-the-middle attack and access in-transit sensitive data. CISA stated that the issues impact Illumina In Vitro Diagnostic (IVD) devices (NextSeq 550Dx and MiSeq Dx) and Researcher Use Only (ROU) instruments (NextSeq 500, NextSeq 550, MiSeq Instrument, iSeq 100, and MiniSeq Instrument) running different versions of LRM. Illumina issued updates to prevent the remote exploitation of these bugs and is working on delivering full patches for them.
SecurityWeek reports: "CISA Warns of Critical Vulnerabilities in Illumina Genetic Analysis Devices"